Concepedia

Thomas T. Kawabata

TT

Statistics

Publications

49

Citations

3.4K

H-Index

27

Active since

1983

Affiliations

Pfizer (United States)(Current)

Virginia Commonwealth University Medical Center

Procter & Gamble (United States)

University Hospital of Bern

University of Iowa

Thomas T. Kawabata is an author at Pfizer (United States) specializing in immunology, life sciences, and pharmacology.

Publications per year

1983–2016

49

Publications

49

Prevention of Organ Allograft Rejection by a Specific Janus Kinase 3 Inhibitor

Paul S. Changelian, Mark E. Flanagan, Douglas J. Ball et al. · Science · 2003 · 670 citations · Full text

, , +17

The mechanism of action of tofacitinib - an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis.

Jennifer Hodge, Thomas T. Kawabata, Sriram Krishnaswami et al. · PubMed · 2016 · 372 citations

, , +17

Herpes Zoster and Tofacitinib Therapy in Patients With Rheumatoid Arthritis

Kevin Winthrop, Hisashi Yamanaka, Hernán Valdez et al. · Arthritis & Rheumatology · 2014 · 350 citations · Full text

, , +17

Immunogenicity of biologically-derived therapeutics: Assessment and interpretation of nonclinical safety studies

Rafael Ponce, Leslie W. Abad, Lakshmi Amaravadi et al. · Regulatory Toxicology and Pharmacology · 2009 · 268 citations

, , +14

Molecular cloning of insect pro-phenol oxidase: a copper-containing protein homologous to arthropod hemocyanin.

Thomas T. Kawabata, Yuki Yasuhara, Mari Ochiai et al. · Proceedings of the National Academy of Sciences · 1995 · 170 citations

, , +13

1–5 of 49